Clinical trial
A Non-Interventional Study to Investigate the Effectiveness of Hydrotalcite to Relieve Acid-Related Symptoms Due to an Acid Rebound After Discontinuation of a Non/No Longer Indicated Long-Term PPI Therapy.
NCT07291700 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Non-Interventional Study to Investigate the Effectiveness of Hydrotalcite to Relieve Acid-Related Symptoms Due to an Acid Rebound After Discontinuation of a Non/No Longer Indicated Long-Term PPI Therapy.
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- November 18, 2025
- Completion date
- October 31, 2026
- Enrollment
- 167 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.